Adolore Biotherapeutics, Inc.: Adolore Biotherapeutics Strengthens Management Team and Board of Directors with the Appointments of Roelof Rongen, MSE, MBA and Mark C. Rogers, MD, MBA

Mr. Rongen appointed as CEO and member of the Board bringing 30 years of executive leadership experience and expertise across a number of therapeutic areasBolstered expertise on Board of Directors with

Related Keywords

Norway ,New York ,United States ,Wageningen ,Gelderland ,Netherlands ,Columbia University ,London ,City Of ,United Kingdom ,Amsterdam ,Noord Holland ,Matinas Biopharma ,Jenene Thomas ,Adolore Biotherapeutics ,Trygg Pharma ,Markc Rogers ,Abbott Abbvie ,Royc Levitt ,Kostenloser Wertpapierhandel ,Johns Hopkins ,Roelof Rongen ,Us Congress ,Glaxosmithkline ,Adolore Biotherapeutics Inc View ,Ibm ,Nasdaq ,Wilkerson Group ,Udall Foundation ,National Academy Of Medicine ,Portfolio Management At Reliant Pharmaceuticals ,Adolore Biotherapeutics Inc ,Molecular Sciences ,Health Network ,Norway Aker Group ,Wharton School At Pennsylvania University ,Company Board Of Directors ,Rd Commercial Development ,Wageningen University ,Arthurd Little Technology Innovation Management ,Northwestern University ,Chief Executive Officer ,Executive Chairman ,Commercial Development ,Baker Group ,Portfolio Management ,Reliant Pharmaceuticals ,Global Product Director ,Immunology Programs ,Technology Innovation Management ,New York City ,Bio Process Technology ,Duke Hospital ,Perkin Elmer ,Chief Technology Officer ,Gibson Oncology ,Innovative Drug Delivery Systems ,Executive Chair ,Arsenic Trioxide ,Acute Promyelocytic Leukemia ,National Academy ,Reagan Udall Foundation ,Medical Doctorate ,Wharton School ,Disease Modifying Anti Pain ,Inc View ,Adolore ,Iotherapeutics ,Trengthens ,Management ,Team ,Board ,Directors ,Appointments ,Roelof ,Dongen ,Park ,Rogers ,